27 април 2022
20:30 ч. - 21:30 ч.
- Безплатно събитие
- Представяне на книга и разговор с автора
- Участвате на живо в Zoom
- Език: английски
- Продължителност: 1 час
Neuropsychology of depression. Dialogue with Shawn McClintock
Major depressive disorder (MDD) in adults across the lifespan is a leading cause of disability worldwide that results in significant morbidity and mortality. Moreover, depression is associated with significant cognitive impairment particularly in the domains of attention and executive function. This presentation will describe the depressive illness, characterize the associated neurocognitive profile, and discuss antidepressant therapeutic associated cognitive effects. Further, the presentation will highlight important and unique features of the new book Neuropsychology of Depression, with a focus on how the book can inform and improve clinical and research practice.
Dr. Shawn McClintock is an Associate Professor and holds the Lydia Bryant Test Distinguished Professorship in Psychiatric Research in the Department of Psychiatry at UT Southwestern Medical Center. Also, he is the Director of Research Training in the Clinical Psychology Doctoral Program in the UT Southwestern Medical Center Graduate School of Biomedical Sciences. Dr. McClintock received his BA in psychology from the University of North Texas (1998), his MS in Rehabilitation Counseling Psychology (2005), PhD in Clinical Psychology (2006), and MS in Clinical Sciences with Distinction (2011) from UT Southwestern Medical Center. He completed postdoctoral training in clinical neuropsychology and mood disorders research as a National Institute of Mental Health (NIMH) T32 Postdoctoral Fellow at UT Southwestern Medical Center, and he completed postdoctoral training in brain stimulation and therapeutic modulation translational research at Columbia University / New York State Psychiatric Institute. Dr. McClintock is a globally recognized expert in the neurocognitive effects of major depressive disorder and antidepressant neuromodulation therapeutics including electroconvulsive therapy and magnetic seizure therapy. He has received grant funding from the National Institutes of Health (NIH) since 2006. Dr. McClintock has published over 100 peer-reviewed articles, 12 books chapters, and is a Co-Editor of the forthcoming book Neuropsychology of Depression that centers around his program of research focused at the intersection of clinical neuropsychology, depression, and antidepressant therapeutic development.